These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28600754)
21. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization. John WS; Wu LT Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587 [TBL] [Abstract][Full Text] [Related]
22. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Gupta A; Patton C; Diskina D; Cheatle M Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482 [TBL] [Abstract][Full Text] [Related]
23. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. Gaither JR; Goulet JL; Becker WC; Crystal S; Edelman EJ; Gordon K; Kerns RD; Rimland D; Skanderson M; Justice AC; Fiellin DA J Addict Med; 2016; 10(6):418-428. PubMed ID: 27610580 [TBL] [Abstract][Full Text] [Related]
24. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Morasco BJ; Duckart JP; Dobscha SK J Gen Intern Med; 2011 Sep; 26(9):965-71. PubMed ID: 21562923 [TBL] [Abstract][Full Text] [Related]
25. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291 [TBL] [Abstract][Full Text] [Related]
26. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records. Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457 [TBL] [Abstract][Full Text] [Related]
27. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors. Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213 [TBL] [Abstract][Full Text] [Related]
28. Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder. Naeger S; Mutter R; Ali MM; Mark T; Hughey L J Subst Abuse Treat; 2016 Oct; 69():64-71. PubMed ID: 27568512 [TBL] [Abstract][Full Text] [Related]
29. National study of discontinuation of long-term opioid therapy among veterans. Vanderlip ER; Sullivan MD; Edlund MJ; Martin BC; Fortney J; Austen M; Williams JS; Hudson T Pain; 2014 Dec; 155(12):2673-2679. PubMed ID: 25277462 [TBL] [Abstract][Full Text] [Related]
30. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study. Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038 [TBL] [Abstract][Full Text] [Related]
31. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. Englander H; Dobbertin K; Lind BK; Nicolaidis C; Graven P; Dorfman C; Korthuis PT J Gen Intern Med; 2019 Dec; 34(12):2796-2803. PubMed ID: 31410816 [TBL] [Abstract][Full Text] [Related]
32. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States. Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362 [TBL] [Abstract][Full Text] [Related]
33. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study. Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600 [No Abstract] [Full Text] [Related]
34. Urine drug testing in chronic pain. Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368 [TBL] [Abstract][Full Text] [Related]
35. Physician Renewal of Chronically Prescribed Controlled Substances Based on Urine Drug Test Results. Hosain F; Lee J; Ata A; Bhullar RK; Chang AK J Prim Care Community Health; 2019; 10():2150132719883632. PubMed ID: 31646927 [No Abstract] [Full Text] [Related]
36. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic. Bakhai S; Thilagar B; Reynolds JL; Leonard KE J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893 [TBL] [Abstract][Full Text] [Related]
37. Variation in Nevada primary care clinicians' use of urine drug testing to mitigate opioid harm. Hartzell SYT; Keller MS; Albertson EM; Liu Y; Larson M; Friedman S J Subst Use Addict Treat; 2023 Feb; 145():208940. PubMed ID: 36880912 [TBL] [Abstract][Full Text] [Related]
38. The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality. Gaither JR; Goulet JL; Becker WC; Crystal S; Edelman EJ; Gordon K; Kerns RD; Rimland D; Skanderson M; Justice AC; Fiellin DA J Gen Intern Med; 2016 May; 31(5):492-501. PubMed ID: 26847447 [TBL] [Abstract][Full Text] [Related]
39. Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019. Lesko CR; Falade-Nwulia OO; Pytell JD; Hutton HE; Fojo AT; Keruly JC; Moore RD; Chander G Addiction; 2023 Nov; 118(11):2193-2202. PubMed ID: 37491566 [TBL] [Abstract][Full Text] [Related]
40. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain. Setnik B; Roland CL; Pixton GC; Sommerville KW Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]